Accuray Incorporated Share Price & Technical Analysis

ARAY · $0.38 (+22.58%)

Healthcare / Medical Devices

AI Score 26 · Bearish

$0.38

+22.58%

Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation th

Price chart

Seasonality

May has 1 positive and 3 negative years (last 5 years shown)

-40% return in May, -3% avg return in past 3 year May month.

-73% return in 2026, -16% avg return in past 3 years.

Swipe sideways to see all months →

JanFebMarAprMayJunJulAugSepOctNovDecYr
260%-25%-33%25%-40%-73%
2516%-9%-10%-17%0%-7%-7%15%13%-18%-21%-27%-71%
24-7%0%-4%-16%-18%0%0%22%-14%-6%22%-9%-30%
2319%16%3%10%9%11%13%-33%-4%-4%0%12%53%
22-23%-5%-3%-18%-22%0%5%14%-9%-5%0%5%-61%

Monthly return % by calendar month · historical pattern, not a forecast

AI snapshotScore 26/100

Bearish · Downtrend · Neutral

Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. It also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, the company offers post-contract customer support, installation, training, and other professional services. It primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.

Full AI Q&A, portfolio tracking, and live alerts in the app.

Key metrics

Market cap

$38.84M

P/E ratio

52W high

$2.10

52W low

$0.25

Volume

12,02,477

Beta

1.43

Related stocks in Healthcare

Frequently asked questions

What is Accuray Incorporated share price today?
Accuray Incorporated (ARAY) last traded around $0.38 on StockPro. Prices refresh every few minutes during market hours.
What technical signals does ARAY have?
StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ARAY. Download the app for real-time alerts.
How can I analyze Accuray Incorporated stock?
Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.

Explore more on StockPro